The two enzymes differ a bit in their affinity for different monoamines
The EVOKE and EVOKE + trials are supported by robust preclinical evidence demonstrating GLP-1RA benefits in neurodegeneration and cognitive enhancement in T2DM patients (Norgaard et al., 2022)
Experimental Physiology 2008;93:1139-1146
For most people taking propranolol for high blood pressure, the added blood pressure reduction with Mounjaro is a benefit
Patients save up to $900/year on an annual plan the equivalent of 6 months free
Wegovy: New clinical trial says this weight-loss medication sheds more pounds The 5 biggest weight loss myths that need to die, according to an obesity doctor GLP-1 drugs like Wegovy are all the ragebut people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study This is the best time of day to exercise for people living with obesity, new study shows Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team